Clinical Trial: A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours
Study Status: Completed
Recruit Status: RECRUITING
Condition: Pancreatic Ductal Adenocarcinoma (PDAC)
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Study of [225Ac]-FPI-2059 in Adult Participants With NTSR1-Expressing Advanced, Metastatic and/or Recurrent Solid Tumours
Brief Summary:
This is a first-in-human Phase 1 clinical trial designed to investigate the safety, tolerability, pharmacokinetics, and biodistribution of [225Ac]-FPI-2059 and [111In]-FPI-2058 in participants with neurotensin receptor 1 (NTSR1)-expressing solid tumours.
Read more